We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Minakem and LibraGen Form Alliance in Biocatalysis and Fine Chemicals Production
News

Minakem and LibraGen Form Alliance in Biocatalysis and Fine Chemicals Production

Minakem and LibraGen Form Alliance in Biocatalysis and Fine Chemicals Production
News

Minakem and LibraGen Form Alliance in Biocatalysis and Fine Chemicals Production

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "Minakem and LibraGen Form Alliance in Biocatalysis and Fine Chemicals Production "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

Minakem and LibraGen have entered into a strategic partnership to give their customers access to a comprehensive range of services and products.

By jointly deploying their marketing and technical resources, the two companies will be able to deliver services and products to customers in many projects where there are synergies between fine chemicals production and biocatalysis.

LibraGen will use its proprietary META-DNA™ technology platform and know-how in applied biocatalysis to generate new biosynthesis routes that will be transferred to Minakem's cGMP compliant facilities for manufacturing.

“We are pleased to establish this partnership with LibraGen and provide additional technology opportunities to our customers, giving them direct access to chiral biocatalysis and Green Chemistry,” said Pierre Charrier, Business Development Director at Minakem.

“Minakem and LibraGen teams will together design innovative and efficient synthesis routes by combining LibraGen's unique skills in applied biocatalysis, and Minakem’s renowned expertise in chemical process development and FDA-approved chemical production facilities.”

“The joint operation will allow a very rapid implementation of the best performing production solutions. These will provide an excellent response to our customers’ budgetary and timeline requirements.”

“This alliance will bring LibraGen additional openings for providing its services to the fine chemicals and pharmaceuticals industry,” said Dr. Renaud Nalin, Chief Executive Officer at LibraGen.

“It is a great opportunity to provide pragmatic biocatalytic processes which, when combined with Minakem's chemistry and production capabilities, offer integrated solutions for the definition and the implementation of the best industrial production processes.”

“We will deploy all the technology available on our biocatalysis platform in these joint projects. This includes enzyme discovery, optimization and applied biocatalysis. We are looking forward to extending our market share through this alliance.”

Advertisement